HIM
RXST icon

Hillsdale Investment Management’s RxSight RXST Stock Holding History

Hillsdale Investment Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-70,010
Closed -$3.46M – 667
2024
Q3 		$3.46M Sell
70,010
-20
-0% -$1.02K 0.27% 152
2024
Q2 		$4.21M Sell
70,030
-6,100
-8% -$349K 0.33% 89
2024
Q1 		$3.93M Buy
76,130
+75,980
+50,653% +$3.73M 0.31% 129
2023
Q4 		$6.05K Buy
+150
New +$4.4K ﹤0.01% 500

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Hillsdale Investment Management's RXST Position: Q4 2024 in Review

Hillsdale Investment Management sold out of RxSight (RXST) in Q4 2024, closing a stake of 70,010 shares — an estimated $3.46M sold.

Hillsdale Investment Management first reported a position in RXST in Q4 2023 and held it in 4 quarters. The position peaked at $4.21M in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Hillsdale Investment Management reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 70,010 RxSight shares in Q4 2024, an estimated $3.46M.
  • Hillsdale Investment Management first reported a position in RxSight in Q4 2023 and held it in 4 quarters.
  • Hillsdale Investment Management's RxSight position peaked at $4.21M in Q2 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Hillsdale Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.